SFAM
ABVX

Springhill Fund Asset Management’s Abivax ABVX Stock Holding History

Springhill Fund Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-207,600
Closed -$1.52M – 20
2024
Q4 		$1.52M Buy
+207,600
New +$1.91M 2.47% 16

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Springhill Fund Asset Management's ABVX Position: Q1 2025 in Review

Springhill Fund Asset Management sold out of Abivax (ABVX) in Q1 2025, closing a stake of 207,600 shares — an estimated $1.52M sold.

Springhill Fund Asset Management first reported a position in ABVX in Q4 2024 and held it in 1 quarter. The position peaked at $1.52M in Q4 2024. 46 funds tracked by Wall St. Rank hold ABVX as of Q1 2025.

  • Springhill Fund Asset Management reported no remaining Abivax position as of Q1 2025 after selling out during the quarter.
  • Springhill Fund Asset Management sold 207,600 Abivax shares in Q1 2025, an estimated $1.52M.
  • Springhill Fund Asset Management first reported a position in Abivax in Q4 2024 and held it in 1 quarter.
  • Springhill Fund Asset Management's Abivax position peaked at $1.52M in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Abivax as of Q1 2025.

Based on Springhill Fund Asset Management's 13F filing for Q1 2025, filed 14 May 2025.